​

Citius Oncology Ownership | Who Owns Citius Oncology?


OverviewChart

Citius Oncology Ownership Summary


Citius Oncology is owned by 13.11% institutional investors, 77.51% insiders, and 9.38% retail investors. Vanguard capital management is the largest institutional shareholder, holding 0.51% of CTOR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.40% of its assets in Citius Oncology shares.

CTOR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCitius Oncology13.11%77.51%9.38%
SectorHealthcare Stocks 247.07%12.15%-159.22%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard capital management546.33K0.51%$551.79K
Geode capital management281.93K0.26%$284.75K
Vanguard fiduciary trust175.10K0.16%$176.85K
State street42.90K0.04%$43.33K
Hrt financial lp31.23K0.03%$31.00K
Private advisor group25.00K0.02%$25.25K
Captrust financial advisors21.00K0.02%$21.21K
Ubs group13.98K0.01%$14.12K
Stonex group13.72K0.01%$12.34K
Advisor group1.00K0.00%$1.01K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Stonex group13.72K0.00%$12.34K
Private advisor group25.00K0.00%$25.25K
Hrt financial lp31.23K0.00%$31.00K
State street42.90K-$43.33K
Ubs group13.98K-$14.12K
Captrust financial advisors21.00K-$21.21K
Citigroup1.00-$1.00
Morgan stanley---
Blackrock funding, inc. /de---
Caitong asset management1.00-$1.00

Top Buyers

HolderShares% AssetsChange
Vanguard fiduciary trust175.10K-53.19K
Geode capital management281.93K-36.52K
Hrt financial lp31.23K0.00%31.23K
Private advisor group25.00K0.00%25.00K
Captrust financial advisors21.00K-21.00K

Top Sellers

HolderShares% AssetsChange
Ubs group13.98K--320.64K
Blackrock funding, inc. /de---47.45K
Barclays---90.00
Morgan stanley---23.00
Advisor group1.00K--

New Positions

HolderShares% AssetsChangeValue
Hrt financial lp31.23K0.00%31.23K$31.00K
Private advisor group25.00K0.00%25.00K$25.25K
Captrust financial advisors21.00K-21.00K$21.21K
Stonex group13.72K0.00%13.72K$12.34K
Citigroup1.00-1.00$1.00

Sold Out

HolderChange
Morgan stanley-23.00
Barclays-90.00
Blackrock funding, inc. /de-47.45K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20262053.85%14,145,477-0.72%136.46%1011.11%3200.00%
Mar 31, 202613-23.53%14,247,638107.66%1423.15%9-10.00%1-75.00%
Dec 31, 2025176.25%6,861,177-17.90%76.03%10-23.08%4100.00%
Sep 30, 202516128.57%8,357,1593573.61%1111285.28%13160.00%2100.00%
Jun 30, 20257-227,49294.43%-1189.17%566.67%1-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv370.10K0.40%-
Vanguard Morn Total Stk Mkt Idx Investor370.10K0.40%-
Vanguard MStar Total Stk Mkt Idx Invest370.10K0.35%-
Vanguard Institutional Extnd Mkt Idx Tr176.22K0.21%-
Fidelity Extended Market Index133.58K0.13%36.09K
Fidelity Nasdaq Composite Index54.73K0.05%-
iShares Micro-Cap ETF44.96K0.05%-
Spartan Extended Market Index Pool F29.84K0.03%163.00
NT Ext Equity Mkt Index Fund - Lending23.37K0.03%-
Northern Trust Extended Eq Market Idx23.37K0.03%-

Insider Transactions Trends


DateBuySell
2026 Q4--
2026 Q3--
2025 Q3--
2024 Q4--
2024 Q3--

CTOR Ownership FAQ


Who owns the most shares of Citius Oncology?

Citius Oncology’s largest shareholders are Vanguard capital management (546.32K shares, 0.51%), Geode capital management (281.93K shares, 0.26%), and Vanguard fiduciary trust (175.1K shares, 0.16%). Together, they hold 0.93% of Citius Oncology’s total shares outstanding.

Does Blackrock own Citius Oncology?

BlackRock is not among the top 10 institutional shareholders of Citius Oncology.

Who is Citius Oncology’s biggest shareholder by percentage of total assets invested?

Stonex group is Citius Oncology’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 13.72K Citius Oncology shares, valued at 12.34K$.

Who is the top mutual fund holder of Citius Oncology shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Citius Oncology shares, with 0.40% of its total shares outstanding invested in 370.1K Citius Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools